Top Biotechnology & Medical Research stocks in Australia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
au flag iconTLXTelix PharmaceuticalsAU$4.48bn98.3n/a
au flag iconMSBMesoblastAU$2.30bnn/an/a
au flag iconPYCPYC TherapeuticsAU$1.75bnn/an/a
au flag iconCGSCogstateAU$591.32m28.911.13%
au flag iconCU6Clarity PharmaceuticalsAU$585.56mn/an/a
au flag iconRACRacura OncologyAU$310.77mn/an/a
au flag iconTTXTetratherixAU$272.08mn/an/a
au flag iconACWActinogen MedicalAU$170.99mn/an/a
au flag iconPARParadigm BiopharmaceuticalsAU$143.29mn/an/a
au flag iconDXBDimerixAU$117.08mn/an/a
au flag iconNYRNyradaAU$108.72mn/an/a
au flag iconILAIsland PharmaceuticalsAU$96.17mn/an/a
au flag iconGD8GO-DX (Aust)AU$84.74mn/an/a
au flag iconLTPLtr PharmaAU$80.89mn/an/a
au flag iconALAArovella TherapeuticsAU$61.65mn/an/a
au flag iconPTXPrescient TherapeuticsAU$56.78mn/an/a
au flag iconATHAlterity TherapeuticsAU$55.46mn/an/a
au flag iconENPEntropy NeurodynamicsAU$52.13mn/an/a
au flag iconADOAnteotechAU$45.64mn/an/a
au flag iconATXAmplia TherapeuticsAU$41.05mn/an/a